Mikrogen GmbH

MIKROGEN

Diagnostic agents, for medical and pharmaceutical purposes, namely, medical diagnostic reagents and radioactive pharmaceutical preparations for in vivo diagnostic use; biochemical agents and preparations for pharmaceutical purposes, namely, pharmaceuticals for use in diagnosing bacterial and viral infectious diseases and autoimmune diseases; diagnostic agents for medical purposes, namely, recombinantly or synthetically produced antigens for medical, in particular diagnostic purposes; diagnostic agents for medical purposes, namely, lysates of microorganisms, in particular preparations of components of microorganisms usable for diagnostic purposes; diagnostic agents for carrying out serologic tests for medical purposes; biochemical preparations for carrying out verification tests for medical purposes, namely, diagnosis of bacterial and viral infectious diseases and autoimmune diseases ; diagnostic preparations for medical use, namely, diagnostic preparations for carrying out western blot tests for medical purposes; diagnostic preparations for medical use, namely, diagnostic preparations for carrying out enzyme immune tests for medical purposes; diagnostic reagents for serologic test of infections for medical purposes;Diagnostic agents, namely, reagents and diagnostic preparations for scientific purposes; biochemical agents and preparations, namely, reagents, for scientific purposes, in particular recombinantly produced proteins and peptides; chemical and biochemical reagents and genetic identity tests comprised of reagents for the identification of DNA by means of PCR technology and hybridization;Services of a medical, bacteriological and biochemical laboratory, in particular chemical synthesis of oligonucleotides; scientific analysis regarding reagents and probes for the identification of DNA by means of PCR technology and hybridization; research and development services in the field of bacteriology, cytology, antibody technology, chemistry, immunology and gene expression systems, in particular regarding cloning, expression and purification of proteins and antigens for third parties; biochemical research and development for recombinant production of partially purified proteins of microorganisms;

T-TRACK

Medicines for use in treating infectious diseases and autoimmune disorders and for use in immune monitoring; pharmaceutical and veterinary preparations for use in treating infectious diseases and autoimmune disorders and for use in immune monitoring; vaccines; chemical, biochemical and biological products and preparations for medical purposes, namely, diagnostic preparations and analysis preparations for medical purposes, eukaryotic cells, cultures of microorganisms, nucleic acids, polypeptides, protein supplements comprised of cytokines, antibodies and T-cell proteins and enzymes for infectious and autoimmune disorders;Chemical, biochemical and biological products and preparations used in industry and science, namely, diagnostic and analysis preparations other than for medical or veterinary purposes, eukaryotic cells for scientific laboratory or medical research, cultures of microorganisms other than for medical and veterinary use, nucleic acids for laboratory use, polypeptides for laboratory use, proteins antibodies and T-cell proteins for scientific, laboratory or medical research and enzymes for industrial purposes;Molecular biological or biotechnological laboratory services, namely, research and development in the field of human and veterinary diagnostics and therapy identification of epitopes and identification of target structures for the development of medicines and vaccines; development of medicines, vaccines, diagnostic preparations, analysis and diagnostic apparatus and systems; development of technologies for scientific and industrial research and production, namely, T-cell-based products for diagnosis, therapy and prevention of autoimmune and infectious disorders, development of test procedures and test kits; scientific and technological services, namely, development of eukaryotic cells, microorganisms, nucleic acids, polypeptides, proteins, namely, antibodies and T-cell proteins, enzymes; development of computer programs and databases; scientific and technological analysis of cells, nucleic acids and polypeptides by means of computer programs and databases;